GPER1 and pancreatic neoplasm: In pancreatic cancer, high GPER1 expression has been associated with improved survival [27], and GPER1 activation leads to peritumoral mesenchymal remodelling in PDAC, reducing fibrous tissue proliferation, inflammation and immunosuppression [28].